Bill > SB61

This bill aims to enact a new section of the Ohio Revised Code (Section 3902.63) to cap the cost-sharing (such as deductibles, copays, or coinsurance) that health plan issuers can require for prescription insulin drugs at $35 per 30-day supply, regardless of the amount or type of insulin needed. The new law would apply to health benefit plans amended, issued, or renewed on or after the effective date of this section. The term "prescription insulin drug" is defined as a prescription drug that contains insulin and is used to treat diabetes.